Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis
Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis
Linjing Zhou, Yunfeng Tong, Yunfei Chen, Le Wang et al.
Citations
3 citations
Journal
Therapeutic Advances in Medical Oncology
Topics
Lung Cancer Research Studies
Field-Weighted Citation Impact (FWCI)
3.14
article
Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis
Linjing Zhou, Yunfeng Tong, Yunfei Chen, Le Wang, Kaiyan Chen, Yun Fan, Jing Sun, Siqi Zhou, Y W Li
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Therapeutic Advances in Medical OncologyVol. 17
Institutions
Zhejiang Chinese Medical University (CN), Wenzhou Medical University (CN), Zhejiang Cancer Hospital (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis — Linjing Zhou, Yunfeng Tong, et al. · Therapeutic Advances in Medical Oncology (2025) | TGRS Research Map | TGRS